Simó-Servat O - Search Results

1

Somatostatin and diabetic retinopathy: an evolving story.

Simó-Servat O, Hernández C, Simó R. Simó-Servat O, et al. Endocrine. 2018 Apr;60(1):1-3. doi: 10.1007/s12020-018-1561-0. Epub 2018 Feb 20. Endocrine. 2018. PMID: 29464407 No abstract available.

2

Psychometric validation of the MIND Youth Questionnaire (MY-Q) to assess quality of life in Spanish patients with type 1 diabetes between 12 and 25 years old.

Rudilla D, García E, Ortiz-Zúñiga ÁM, León MC, Nattero-Chávez L, Mingorance A, Prado A, Galiana L, Oliver A, Simó-Servat O. Rudilla D, et al. Endocrinol Diabetes Nutr (Engl Ed). 2023 Jan;70(1):4-13. doi: 10.1016/j.endien.2022.07.012. Endocrinol Diabetes Nutr (Engl Ed). 2023. PMID: 36764747

3

Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy.

Simó-Servat O, Hernández C, Simó R. Simó-Servat O, et al. Mediators Inflamm. 2012;2012:872978. doi: 10.1155/2012/872978. Epub 2012 Sep 17. Mediators Inflamm. 2012. PMID: 23028204 Free PMC article. Review.

4

Genetics in diabetic retinopathy: current concepts and new insights.

Simó-Servat O, Hernández C, Simó R. Simó-Servat O, et al. Curr Genomics. 2013 Aug;14(5):289-99. doi: 10.2174/13892029113149990008. Curr Genomics. 2013. PMID: 24403848 Free PMC article.

5

Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives.

Hernández C, Simó-Servat O, Simó R. Hernández C, et al. Endocrine. 2014 Jun;46(2):209-14. doi: 10.1007/s12020-014-0232-z. Epub 2014 Mar 14. Endocrine. 2014. PMID: 24627166 Review.

6

Is fenofibrate a reasonable treatment for diabetic microvascular disease?

Simó R, Simó-Servat O, Hernández C. Simó R, et al. Curr Diab Rep. 2015 May;15(5):24. doi: 10.1007/s11892-015-0599-0. Curr Diab Rep. 2015. PMID: 25772642 Review.

7

Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology.

Simó-Servat O, Simó R, Hernández C. Simó-Servat O, et al. J Diabetes Res. 2016;2016:5263798. doi: 10.1155/2016/5263798. Epub 2016 Jun 8. J Diabetes Res. 2016. PMID: 27376090 Free PMC article. Review.

8

Cognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist's perspective.

Simó R, Ciudin A, Simó-Servat O, Hernández C. Simó R, et al. Acta Diabetol. 2017 May;54(5):417-424. doi: 10.1007/s00592-017-0970-5. Epub 2017 Feb 16. Acta Diabetol. 2017. PMID: 28210868 Review.

9

Type 2 diabetes is an independent risk factor for dementia conversion in patients with mild cognitive impairment.

Ciudin A, Espinosa A, Simó-Servat O, Ruiz A, Alegret M, Hernández C, Boada M, Simó R. Ciudin A, et al. J Diabetes Complications. 2017 Aug;31(8):1272-1274. doi: 10.1016/j.jdiacomp.2017.04.018. Epub 2017 Apr 19. J Diabetes Complications. 2017. PMID: 28545893

10

Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.

Hernández C, Bogdanov P, Solà-Adell C, Sampedro J, Valeri M, Genís X, Simó-Servat O, García-Ramírez M, Simó R. Hernández C, et al. Diabetologia. 2017 Nov;60(11):2285-2298. doi: 10.1007/s00125-017-4388-y. Epub 2017 Aug 4. Diabetologia. 2017. PMID: 28779212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters